The effects of MK-801 (0.5 mg/kg i.v.), a non competitive N-methyl-D-aspartate (NMDA) antagonist, upon local cerebral glucose utilisation were examined in conscious, lightly restrained rats and in rats anaesthetised with halothane in nitrous oxide by means of the quanti tative autoradiographic [14C]-2-deoxyglucose technique. In the conscious rats, MK-80 1 produced a heterogenous pattern of altered cerebral glucose utilisation with signif icant increases being observed in 12 of the 28 regions of gray matter examined and significant decreases in 6 of the 28 regions. Pronounced increases in glucose use were ob served after MK-80 1 in the olfactory areas and in a num ber of brain areas in the limbic system (e.g., hippocampus molecular layer, dentate gyrus, subicular complex, pos terior cingulate cortex, and mammillary body). In the ce rebral cortices, large reductions in glucose use were ob served after administration of MK-801, whereas in the extrapyramidal and sensory-motor areas, glucose use re mained unchanged after MK-801 administration in con scious rats. In the halothane-anaesthetised rats, the pat tern of altered glucose use after MK-80 1 differed qualita tively and quantitatively from that observed in conscious rats. In anaesthetised rats, significant reductions in glu cose use were noted after MK-80 1 in 10 of the 28 regions
( + )-5-Methyl-l0, II-dihydro-5H-dibenzo [a,d] cy clohepten-5,10-imine maleate (MK-80l) is a highly potent and selective noncompetitive N-methyl-D aspartate (NMDA) receptor antagonist (Cline schmidt et ai., 1982; Wong et ai., 1986 Wong et ai., , 1988 . examined, with no area displaying significantly increased glucose use after administration of the drug. In halothane anaesthetised rats, MK-80 1 failed to change the rates of glucose use in the olfactory areas, the hippocampus mo lecular layer, and the dentate gyrus. In the subicular com plex, the posterior cingulate cortex, and the mammillary body, the pattern of the metabolic response to MK-801 was reversed with halothane anaesthesia, with significant reductions in glucose use being observed. In the cerebral cortices (particularly the auditory, sensory-motor, and frontal cortex), the decreases in glucose use following MK-801 in anaesthetised animals were qualitatively sim ilar but quantitatively less marked than those in conscious animals. The rates of glucose use in the extrapyramidal and sensory-motor areas, except for the caudate nucleus, were unchanged by the administration of MK-801 in the anaesthetised animals. These data indicate that the func tional consequences in vivo of blockade of NMDA recep tors are markedly modified by halothane anaesthesia. The divergent responses to MK-80 1 emphasise the difficulties in the extrapolation of data from anaesthetised rats to conscious rats. Key Words: ['4C]-2-deoxyglucose autora diography-Glucose utilisation-Halothane-MK-801-N-methyl-D-aspartate receptor.
Systemic administration of MK-801 induces marked regionally heterogenous alterations in local cerebral glucose use in conscious rats, most notably in the limbic system and in the neocortex (Kurumaji et ai., 1989; Nehls et ai., 1988) . The functional conse quences (as reflected in local levels of glucose util isation) of NMDA receptor blockade in the con scious animal correspond poorly with the electro physiological effects of NMDA antagonists that have been described in brain slices in vitro or in anaesthetised animals (Collingridge and Bliss, 1987; Abraham and Mason, 1988) . General anaesthesia results in profound disturbances in synaptic trans mission in the CNS, in the structure and function of cellular membranes, and in most cerebral metabolic processes (such as cyclic nucleotide metabolism, the level and turnover of neurotransmitters, oxida tive catabolism of glucose, and energy generation) (Koblin and Eger, 1986; Siesjo, 1987) . However, in spite of these widely recognised effects of general anaesthetics, anaesthesia remains a necessary, in tegral feature of many electrophysiological and neu rochemical investigations.
Glucose utilisation constitutes the primary en ergy-generating metabolic process in cerebral tissue of well-nourished, mature animals (Sokoloff et aI, 1977) . As a consequence of the close coupling that exists between energy production and functional events in the CNS (Sokoloff, 1981) , determining the rates of glucose use by means of the e4C]-2-deoxy glucose technique (Sokoloff et aI., 1977 ) provides considerable insight into the level of functional ac tivity in discrete brain regions. One major advan tage of the e4C]-2-deoxyglucose technique is that functional processes can be mapped as readily in conscious animals as in anaesthetised animals (Mc Culloch, 1982) .
As well as providing an indirect measure of func tional events, the level of local cerebral glucose use is the primary determinant of local cerebral blood flow in normal circumstances (Sokoloff, 1981; Kuschinsky and Wahl, 1978) . However, in cerebral ischaemia, it is the mismatch between substrate de livery (cerebral blood flow) and substrate utilisation (oxidative catabolism of glucose) that triggers the sequence of neurochemical events leading ulti mately to neuronal death. NMDA receptor antago nists can markedly reduce ischaemic brain damage in some models of cerebral ischaemia (Simon et al., 1984; Gill et aI., 1987; Ozyurt et aI., 1988; Park et aI., 1988a,b) . Alterations in glucose utilisation as a consequence of NMDA antagonists might contrib ute to or complicate the anti-ischaemic effects of the drug. General anaesthesia, either throughout the postischaemic survival period or temporarily during the induction of the ischaemia is a common feature in animal models of cerebral ischaemia. No reliable information exists, at present, on the effects of specific NMDA receptor antagonists on cerebral oxidative metabolism in anaesthetised animals, compared with those in conscious animals.
MATERIALS AND METHODS

Animals
The experiments were performed on 20 male Sprague Dawley rats with a mean weight of 375 g. There were no significant differences in the mean weight of animals in each group though there was some variability in weight in the two anaesthetised groups (Table 1) . Such variability is suboptimal, as the impact of animal age on the cerebral metabolic responses to NMDA receptor antagonists has not been determined. The rats were maintained under a controlled lighting and thermal environment and were al lowed free access to food and water until the experiments began. The investigations were carried out under a pro ject licence approved by the Home Office of Her Majes ty's government. 
Preparation of animals
On the day of the experiment, polyethylene catheters were introduced into both femoral arteries (for the con tinuous monitoring of arterial blood pressure and the in termittent sampling of arterial blood) and veins (for the administration of drugs or radioisotopes) during a brief (approximately 45 min) period of light halothane anaes thesia (1 % in 70% nitrous oxide/30% oxygen). Nine of the animals were fitted with a loose plaster cast around the lower abdomen for restraint, as described by Sokoloff et a!. (1977) . The anaesthetic gas mixture was withdrawn and the rats allowed to recover from the effects of anaes thesia for at least 2 h before any further manipulations were performed, at which time the conscious, lightly re strained animals displayed normal grooming behaviour and appropriate reactions to slight auditory or sensory stimuli. The remaining 11 rats were tracheotomised and connected to an intermittent, positive-pressure, small animal ventilation pump. After the introduction of cath eters, the concentration of halothane was reduced from 1 % to 0.5%, and this level of anaesthesia was maintained for at least 30 min before any further manipulations. The conscious and unconscious animals were main tained normothermic (rectal temperature 37°C) by means of a heating lamp and a heating blanket with feedback control via a rectal thermometer (Homoeothermic Blan ket Control, Bioscience, Sheerness, U.K.), respectively.
Measurement of local cerebral glucose utilisation
A detailed description of the theoretical basis and tech nical details for determining cerebral glucose utilisation with e 4Cjdeoxyglucose was published previously (Sokoloff et a!., 1977) , and the present experiments were performed in accordance with those descriptions.
MK-801 (0.5 mg/kg), freshly dissolved in saline, was injected intravenously 10 min prior to the measurement of cerebral glucose utilisation. Control animals received a similar volume of vehicle. The measurement of glucose use was initiated 10 min after drug or vehicle treatment by the intravenous administration, over 30 s, of 125 !LCi/kg [14C]2-deoxyglucose in 0.7 ml physiological saline. Four teen timed arterial blood samples were taken throughout the following 45 min. The blood samples were centrifuged immediately, and the plasma was assayed for 14C activity by liquid scintillation counting and for glucose concentra tion (Glucose Analyzer 2, Beckman, High Wycombe, U.K.). Approximately 35 min after administration of 2-deoxyglucose, a sample of arterial blood gas was taken for analysis of Pac02, Pa02, and pH by a blood gas anal yser (Corning, Halstead, U.K.). At 45 min after radioiso tope administration, the rats were killed by decapitation, and the brains were removed and frozen in isopentane chilled with dry ice at -45°C. The frozen brains were cut into 20 !Lm sections at -22°C in a cryostat, and 3 in every 10 sections were mounted on glass coverslips and then dried rapidly on a hot plate at 60°C. The brain sections were placed against x-ray plates (Kodak GRL) along with precalibration plastic standards (concentration range 44-1,475 nCi/g) for 14 and 18 days for anaesthetised and con scious animals, respectively. Local tissue concentrations of 14C were determined through quantitative densitomet ric analysis by a computer-based densitometry system (Quanti met 970, Cambridge Instruments, Cambridge, U.K.). For each area of the brain in every animal, 12 bilateral density readings were made on a series of six sections in which the structure could be defined anatom ically by reference to a stereotaxic atlas (Paxinos and Watson, 1982) . Local cerebral glucose utilisation was cal culated using the operational equation for the technique from the plasma of 14C and glucose levels (Sokoloff et a!., 1977) .
Statistical analysis
Data are presented as mean ± SEM. Glucose use in each brain area was analysed independently. Statistical J Cereb Blood Flow Metab, Vol. 9, No. 6, 1989 differences in measured variables were analysed by one way analysis of variance (ANOV A), followed by two tailed Student's t test; because of the three comparisons of interest between the four experimental groups, the Bonferroni correction for a-level was employed to main tain the overall a-level at 0.05.
RESULTS
MK-801 (0.5 mg/kg i.v.) effected significant alter ations in mean arterial blood pressure. In con scious, lightly restrained animals, MK-801 effected an immediate, transient (less than 5 min) increase in mean arterial pressure (mean increase at peak from preinjection levels 29 ± 6 mm Hg, p < 0.01, paired t test). In halothane-anaesthetised rats, MK-801 ef fected a decrease in mean arterial pressure (mean decrease at nadir from preinjection level 39 ± 9 mm Hg, p < 0.02, paired t test). The MK-801-induced hypotension was relatively persistent: even at the end of the glucose use measurement, 55 min after drug administration, mean arterial pressure re mained approximately 20% below preinjection lev els. The injection of the vehicle (saline) was without significant effect in either conscious or anaesthe tised rats. MK-801 had no significant effect upon respiratory blood gas status in conscious or anaes thetised rats, although arterial plasma glucose was significantly lower in anaesthetised animals treated with MK-801 (Table 1) .
In conscious animals, the intravenous injection of MK-801 produced prominent behavioural alter ations characterised by cataleptic responses (e.g., opened eyes, stretched neck, and reduced sensitiv ity to external tactile stimuli). Three animals that received MK-801 displayed a stereotyped repetitive head movement (quick side-to-side or slow up and-down), which persisted throughout the mea surement of glucose use. In halothane-anaes thetised animals, MK-801 produced no overt behav ioural changes.
Effects of halothane anaesthesia upon local cerebral glucose utilisation
Halothane anaesthesia per se induced heteroge nous alterations in local cerebral glucose utilisation. Significant increases in glucose use were observed, in the halothane-anaesthetised animals, in all of the olfactory areas examined and some other limbic ar eas (hippocampus molecular layer, dentate gyrus, subicular complex, and mammillary body) ( Table  2 ). Significant decreases in glucose use were ob served in some cerebral cortex areas (auditory, frontoparietal somatosensory, sensory-motor, and frontal cortices) (Table 3, Fig. 1) , and the ventro lateral thalamic nucleus (Table 4) in halothane anaesthetised animals relative to controls. How- ever, halothane failed to alter significantly the rates of glucose utilisation in a large number of the brain areas (13 regions of 28 gray matter areas studied including posterior cingulate cortex, substantia ni gra, and caudate nucleus) (Tables 2 and 4 , Fig. 1 ).
Effects of MK-801 upon local cerebral glucose utilisation
Conscious, lightly restrained rats. The intrave nous administration of MK-801 (0.5 mg/kg) pro duced heterogenous patterns of altered cerebral glu cose utilisation in the conscious animals, with sig nificant increases in glucose use being observed in 12 regions and significant decreases in 6 of the 28 regions studied. In all of the olfactory regions ex amined and in a number of brain areas in the limbic system (hippocampus molecular layer, dentate gy rus, subicular complex, entorhinal cortex, posterior cingulate cortex, mammillary body, and anteroven tral thalamic nucleus), pronounced increases in glu cose use were observed after MK-801 administra tion (Table 2, Figs. 1 and 2 ). In the cerebral cortices (layer IV) (Table 3, Figs. 1 and 2 ), large reductions in glucose use were noted in animals who received MK-801. However, there were minimal changes in glucose use in the extrapyramidal and sensory motor areas in rats who received MK-801 compared with saline-treated control rats (Table 4) .
Rats anaesthetised with halothane in nitrous ox ide/oxygen. In the halothane-anaesthetised rats, the intravenous administration of MK-801 (0.5 mg/kg) effected significant reductions in glucose use in 10 of the 28 regions studied, with no area displaying significant increases after administration of the drug. In anaesthetised rats, MK-801 failed to alter significantly the rates of glucose use in the olfactory TABLE 3. Cerebral cortex-effe cts of MK-801 (0.5 mg/kg) upon glucose utilisation in conscious rats and in rats anaesthetised with halothane
Conscious
Halothane-anaesthetised
Visual cortex 100 ± 2 74 ± 4a 93 ± 9 68 ± 5a Auditory cortex 133 ± 6 85 ± 7" 97 ± 4b 79 ± 4a Parietal cortex 94 ± 3 72 ± 5a 83 ± 4 62 ± 3a Frontoparietal somatosensory cortex 102 ± 6 72 ± 7" 83 ± 3b 65 ± 3a Sensory-motor cortex 97 ± 3 65 ± 5a 72 ± 2b 62 ± 2a Frontal cortex 103 ± 9 69 ± 6" 76 ± 4b 69 ± 5
Data are presented as f1mol/IOO g/min (mean ± SEM). Measurements were made in cortical layer IV for each region. a p < 0.05 for the comparison between saline-treated and MK-801-treated animals. b p < 0.05 for the comparison between conscious and anaesthetised animals that received saline. 
areas, the hippocampal molecular layer, and the dentate gyrus (Table 2 , Fig. 2 ) whereas in all these areas increases in glucose use had been observed following MK-801 treatment in the conscious rat.
In the subicular complex, the posterior cingulate cortex, and the mammillary body, where increased glucose utilisation occurred following administra tion of MK-801 in conscious rats, the pattern of response to MK-801 was reversed with halothane anaesthesia, with decreased glucose utilisation be ing observed following MK-801 treatment in anaes thetised animals (Table 2, Figs. 1 and 2) .
The administration of MK-801 to animals anaes thetised with halothane decreased the rate of glu cose utilisation in the cerebral cortices compared with saline-treated, anaesthetised animals ( Table 3) . However, in those animals anaesthetised with halo thane, reductions in glucose utilisation in the audi tory (Fig. 2) , the sensory-motor (Fig. 1) , and the frontal cortices were attenuated compared with those in the conscious animals. In anaesthetised an imals, glucose use in the extrapyramidal and sen sory-motor areas, except the caudate nucleus, was
CONSCIOUS ANAESTHETISED
unchanged by the administration of MK-801 (Ta ble 4).
DISCUSSION
The purpose of this study was to examine the effects of light halothane anaesthesia on the cere bral metabolic effects of the NMDA receptor antag onist MK-801. En passant, the study provides fur ther confirmation of the marked effects of anaes thetic agents upon local cerebral glucose utilisation. As anaesthesia represents a gross alteration in CNS function, it is hardly surprising that all general anaesthetics examined hitherto elicit pronounced alterations in function-related glucose use (Sokoloff et aI., 1977; Shapiro et aI., 1978; lngvar et aI., 1980; Crosby et aI., 1982; Dudley et aI., 1982; Savaki et aI., 1983a; Davis et aI., 1984 Davis et aI., , 1986 Ori et aI., 1986; Weissman et aI., 1987) . The present data on the effects of light halothane anaesthesia are in general accord with the detailed report from Savaki et al. (1983a) , who employed the same technique for as sessing cerebral glucose utilisation and the same TABLE 4. Extrapyramidal and sensory-motor areas-effe cts of MK-801 (0.5 mg/kg) upon glucose utilisation in conscious rats and in rats anaesthetised with halothane
Conscious
Caudate nucleus 83 ± 7 94 ± 3 100 ± 5 72 ± 5a Globus pallidus 52 ± 3 51 ± 3 51 ± 5 52 ± 4 Substantia nigra Pars compacta 59 ± 2 48 ± 2 64 ± 7 65 ± 4 Pars reticulata 53 ± 3 47 ± 2 51 ± 5 59 ± 5 Red nucleus 67 ± 3 61 ± 4 67 ± 5 65 ± 4 Thalamus (ventrolateral) 79 ± 3 71 ± 2 62 ± 4b 65 ± 2 Subthalamic nucleus 69 ± 2 65 ± 3 82 ± 9 83 ± 7 Inferior olivary nucleus 62 ± 4 58 ± 3 67 ± 4 66 ± 2 Cerebral hemisphere 53 ± 2 46 ± 1 42 ± 3b 46 ± 3 Data are presented as fLmolll00 g/min (mean ± SEM). a p < 0.05 for the comparison between saline-treated and MK-801-treated animals. b p < 0.05 for the comparison between conscious and anaesthetised animals that received saline. The hierarchy of local optical densities corresponds to the hierarchy of local rates of glucose utilisation. A: Conscious rats. Left, saline-treated animal. Posterior cingulate cortex (PCC), hippocampus molecular layer (Mol), dentate gyrus (OG), and auditory cortex (AC) are indicated by a solid arrow. Right, MK-801-treated animal. In the posterior cingulate cortex, the hippocampus molecular layer, and the dentate gyrus, optical density is greater in the MK-801-treated conscious rat than in the saline-treated conscious control animal. Optical density in the auditory cortex of MK-801-treated rat is less than the saline-treated animal. B:
Halothane-anaesthetised rats. In the posterior cingulate cortex, optical density in the MK-801-treated (right) anaesthetised rat is less than the saline-treated (left) anaesthetised control animal. Optical densities in the hippocampus molecular layer and the dentate gyrus are minimally changed after the administration of MK-801 in anaesthetised animals.
anaesthetic regimen (with the exception that the anaesthetic gas mixture was delivered via a face mask rather than by positive-pressure ventilation via a tracheal tube). The present study provides, in addition, a more anatomically comprehensive de scription of the alterations in glucose use in the lim bic system than the previous report (Savaki et ai., 1983a) . The magnitude of the increases in glucose use in limbic areas (e.g., hippocampus, dentate gy rus) with halothane anaesthesia in the present re port is greater than that previously described (Sa vaki et ai., 1983a) , although this may be a reflection of avoidance of hypercapnia during anaesthesia in the present study by the use of mechanical ventila tion. Hypercapnia is recognised to produce wide spread reductions in the oxidative catabolism of glucose (Miller et ai., 1975; Borgstrom et ai., 1976; Kliefoth et ai., 1979) , and respiratory depression is a feature of halothane anaesthesia in the absence of mechanical ventilation. The most important infor mation in the present report is that light halothane anaesthesia modifies the pattern of cerebral meta bolic alterations that are associated with the admin istration of MK-801. Such observations are consis-tent with previous reports on the modification by anaesthesia of the cerebral metabolic effects of other neuropharmacologic interventions McCulloch, 1981, 1983; Savaki et al., 1983b) . The marked effect of halothane anaesthesia on the metabolic response to MK-801 has implications for two main areas: the elucidation of the functional significance of NMDA receptor blockade and the evaluation of NMDA receptor antagonists as anti ischaemic compounds. Deoxyglucose autoradiography has been widely employed in neuropharmacology to examine the functional consequences (as reflected in local glu cose utilisation) of drug administration to conscious animals. The administration of competitive and par ticularly noncompetitive NMDA receptor antago nists elicits marked, dose-related alterations in local cerebral glucose utilisation in conscious rats (Nehls et al., 1988; Kurumaji et al., 1989) . These observa tions contrasted with the relatively minor functional role in synaptic transmission of NMDA receptors that has been identified in electrophysiological ex periments in brain slices in vitro or in anaesthetised animals (Collingridge and Bliss, 1987; Abraham and Mason, 1988) . The present report suggests that the use of a general anaesthetic (such as halothane) would result in an underestimation of the functional consequences of NMDA receptor blockade. This is particularly true in terms of the Papez (1937) circuit (hippocampus-mammillary body-anterior thalamic nuclei-cingulate cortex), in which each constituent region displayed a marked increase in glucose use with MK-801 whereas in halothane-anaesthetised rats glucose use was not increased with MK-801 in any anatomical component of the Papez circuit; in two of these regions glucose use was significantly reduced after MK-801 (mammillary body, cingulate cortex). The failure of MK-801 to increase glucose use in anaesthetised animals in the dentate gyrus, anterior thalamus, parasubiculum, and entorhinal cortex cannot be attributed to such a "ceiling," as concentations of MK-801 , in excess of those used in the present study, elicit greater increases in glucose use. However, in the olfactory areas and molecular layer of the hippocampus, the question of a ceiling effect remains open (see Nehls et al., 1988; Kuru maji et al., 1989 for log dose responses of local glu cose use to MK-80l). The regional changes in glu cose utilisation after the administration of NMDA antagonists in conscious animals do not correlate simply with the densities of NMDA receptors (Bowery et al., 1988; Maragos et al., 1988; Monaghan and Cotman, 1985) . In some regions that show high densites of receptors, such as the olfac tory area and hippocampal molecular layer, NMDA antagonists such as MK-801 increased the rates of glucose utilisation. However, the NMDA antago nist failed to produce prominent changes in glucose utilisation in the CAl region of the hippocampus, in which one of the highest densities of NMDA recep tors in the CNS is observed. Although all structural elements within a region will contribute to its rate of glucose utilisation, dynamic alterations in glucose utilisation appear to reflect predominantly activity in the axonal terminal of neuronal pathways (Kade karo et al., 1985 (Kade karo et al., , 1987 . In pharmacological studies, alterations in local cerebral glucose use are not re stricted to regions rich in specific receptors for the agent being studied, but are observed also in areas with mono-and polysynaptic neuronal connections with the receptor-rich regions (McCulloch, 1982) . The neuroanatomical circuits that appear to be in volved in the functional responses to MK-801 and halothane, on the basis of altered glucose use, have been considered at length previously (Nehls et al., 1988; Kurumaji et al., 1989; Savaki et al. 1983a) .
The mechanism by which halothane anaesthetia modifies the CNS response to MK-801 is unclear in regard to its effects on synaptic transmission in polysynaptic circuits and receptor conformation among many possible mechanisms. Irrespective of the responsible mechanisms, the sensitivity to gen eral anaesthesia of the cerebral metabolic response to MK-801 has implications for its use as an anti ischaemic agent. The maintenance of CNS function (and ultimately the survival of the tissue itself) is dependent upon the continuous delivery by the blood of an adequate level of substrates relative to metabolic demand. MK-801 displays marked anti ischaemic effects in many (Gill et al., 1987; Ozyurt et al., 1988; Park et al., 1988a,b) , though not all, experimental models of cerebral ischaemia (Buchan and Pulsinelli, 1989) . The present study indicates that general anaesthesia and the choice of anaes thetic may have a considerable influence upon the effects of the NMDA receptor antagonist upon local glucose use, which might complicate evaluation of its anti-ischaemic effects. The selection of the re gion in which to examine the neuroprotective ef fects of MK-801 may determine the extent to which anaesthesia complicates the anti-ischaemic evalua tion. For example, the presence or absence of halo thane anaesthesia does not influence the effects of MK-801 upon substrate demand in the cerebral cor tex; in contrast, in the hippocampus (the object of much study in ischaemia in the rodent), MK-801 increases oxidative metabolism in conscious ani mals (increasing the possibility of a "false negative" conclusion in anti-ischaemic studies), whereas in halothane anaesthesia, oxidative me tab-olism is unaltered with MK-801 (thus allowing eval uation of its anti-ischaemic effects uncomplicated by the action of the agent on oxidative metabolism). Furthermore, it is well recognised that alteration in local cerebral blood flow is often linked to alteration in local cerebral metabolism after neuropharmaco logical intervention (Sokoloff, 1981; Kuschinsky and Wahl, 1978) . The presence of a general anaes thetic such as halothane may have a considerable bearing on any cerebral blood flow changes ob served in the evaluation of the cerebral circulatory effects of NMDA receptor antagonists.
